The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

CML HealthCare Inc. Wins Pre-analytical Excellence Award

Wednesday, March 20, 2013

CML HealthCare Inc. Wins Pre-analytical Excellence Award11:01 EDT Wednesday, March 20, 2013MISSISSAUGA, ONTARIO--(Marketwire - March 20, 2013) - Management of CML HealthCare Inc. (TSX:CLC) (the "Company" or "CML") is proud to announce that the Company's pre-analytical department at its central laboratory is the 2013 winner of the BD-sponsored, Clinical Laboratory Management Association's ("CLMA") Pre-analytical Excellence Award.The award recognizes laboratory professionals within leading health care organizations that are committed to client safety and quality improvements in the pre-analytical phase of clinical laboratory testing. Recipients must demonstrate leadership, best practices, innovation, and measurable and sustainable pre-analytical improvements. In 2012, CML implemented several process re-engineering initiatives that streamlined specimen flow while optimizing footprint and manpower. The result of these undertakings was improved efficiency and quality, and reduced results turnaround times."We are honored to be recognized as the winner of the CLMA Pre-analytical Excellence Award," said Thomas Wellner, President and CEO of CML HealthCare. "It is a great testament to our team and their continued commitment to drive and manage change with the sole objective of enhancing client care and delivering timely, quality results. We will continue to focus on system-wide process enhancements that will improve our ability to provide timely, quality medical diagnostic information to improve people's lives."About CML HealthCare Inc.Based in Mississauga, Ontario, CML HealthCare Inc. is Canada's leading community-based, medical diagnostic services provider operating 137 client C.A.R.E. centres in Ontario, 84 imaging centres in Ontario and British Columbia, and a reference laboratory in Ontario focused on specialized coagulation testing and equipment calibration for international customers. CML is publicly-traded on the Toronto Stock Exchange under the symbol "CLC" and has approximately 89.8 million common shares outstanding. For more information, please visit and follow us on Twitter @cmlhealthcare.FOR FURTHER INFORMATION PLEASE CONTACT: Contact Information: CML HealthCare Inc.Alice Dunning, MBA, CFADirector, Corporate Communications(905) 565-0043 ext. 3472(905) 565-2844 (FAX)